The Biden administration is rolling out a framework to enforce the government's march-in authorities on drugs developed with taxpayer dollars, saying if drugmakers refuse to make their products "reasonably" available, then the government is prepared to give other companies license to produce those drugs at a lower cost.
Under the Bayh–Dole Act of 1980, the government retains certain rights on any products produced through a public-private partnership using federal funding. This legislation...
Заголовки